Development of a nongenetic mouse model of type 2 diabetes (Q35580004)

9 August 2017

Development of a nongenetic mouse model of type 2 diabetes (English)

1 reference

9 August 2017

1 reference

Elizabeth R Gilbert

1

1 reference

PubMed ID

22164157

9 August 2017

Zhuo Fu

series ordinal

2

1 reference

PubMed ID

22164157

9 August 2017

Dongmin Liu

series ordinal

3

1 reference

9 August 2017

29 November 2011

1 reference

Experimental Diabetes Research

9 August 2017

1 reference

9 August 2017

2011

1 reference

9 August 2017

416254

1 reference

Creative Commons Attribution 3.0 Unported

9 August 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Adaptive beta-cell proliferation is severely restricted with advanced age.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

beta-cell failure in diabetes and preservation by clinical treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

The genetic landscape of type 2 diabetes in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Molecular control of cell cycle progression in the pancreatic beta-cell

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Mechanisms of beta-cell death in type 2 diabetes.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

The development of beta-cell mass: recent progress and potential role of GLP-1.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Clinical review 124: Diabetic dyslipidemia: causes and consequences

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Obesity and insulin resistance

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Dyslipidemia and diabetes: animal models.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226533

Nongenetic mouse models of non-insulin-dependent diabetes mellitus.

12 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Nongenetic model of type 2 diabetes: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F416254

Selecting the "right" mouse model for metabolic syndrome and type 2 diabetes research

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22164157

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The value of stereology in analysing structure and function of cells and organs*

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22164157

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2011/416254

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

PubMed ID

22164157